HomeCONGRESS

CONGRESS

View Category
Highlights

FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI

Patients with peripheral vascular disease or prior acute myocardial infarction (especially within the first two years after the event)...
solaci -
Learn More
Chronic Ischemic cardiopathy

TRICS III: Restrictive Transfusion Was Noninferior to Liberal Use in Patients Who Undergo Cardiac Surgery

A large study conducted in 19 countries has found that a policy of restrictive red-cell transfusion during cardiac...
solaci -
Learn More
AHA 2017

AHA 2017

Here you will find the highlights of the AHA Conference 2017, held on November 11-15 in the city...
solaci -
Learn More
Chronic Ischemic cardiopathy

TCT 2017 | FAME 2 at 3 Years: Better Results with Angioplasty and at a Cost Similar to Medical Treatment

Courtesy of SBHCI. Angioplasty in patients with chronic stable angina and functionally significant lesions improves clinical outcomes and...
solaci -
Learn More
Chronic Ischemic cardiopathy

TCT 2017 | ORBITA: The Placebo Effect of Angioplasty

Courtesy of the SBHCI. Chronic stable angina and severe coronary lesion patients who undergo angioplasty in a single...
solaci -
Learn More
Other

TCT 2017 | PREVAIL: Final Outcomes of the Watchman Device

Courtesy of SBHCI. The final 5-year outcomes of the PROTECT AF and PREVAIL studies (which assessed the left...
solaci -
Learn More
SOLACI

TCT 2017 | The TRI-REPAIR and the FORMA Trials: New Devices for the “Forgotten Valve”

Courtesy of SBHCI. Two new transcatheter treatments for severe or massive functional tricuspid regurgitation have showed good results...
solaci -
Learn More
Antiplatelet

TCT 2017 | SENIOR: DES with a Bioresorbable Polymer and Short Dual Antiplatelet Therapy in Elderly Patients

 Courtesy of the SBHCI. This study sought to assess the safety and efficacy of an everolimus-eluting stent with...
solaci -
Learn More